TELO: Nilai perusahaan marang bathi resik Telomir Pharma

Lambang korporat lan logo Telomir Pharmaceuticals Inc (TELO)

Telomir Pharmaceuticals (TELO) is currently aggressively spending its available cash on operating activities without generating current revenue. High scientific risks associated with anti-aging research create a threat of zero profitability. This share price chart featuring the -0.70 metric visualizes the asset's price action. The business relies on the study of telomere regulation, expanding its portfolio with veterinary projects and fibrosis treatments to hedge its investments.

TELO Telomir Pharmaceuticals Corp: Koefisien rega marang bathi ing interval 21.02.2024 - 16.11.2026

Rincian metrik komprehensif lan analitis Telomir Pharmaceuticals Inc (TELO)

- rega lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:Telomir Pharma - TELO
Barang unggulan Telomir Pharmaceuticals, Inc.

An investment audit of the issuer requires a P/E analysis, calculated as the ratio of market capitalization to net income, which determines the payback period for investments based on current earnings. For Telomir Pharmaceuticals (TELO), which is establishing R&D barriers in the fight against aging, a P/E business valuation allows for the correlation of innovative molecule value with actual profitability, preventing overpayment for technological expectations.

Perusahaan pesaing

HLN: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi KVUE (Kenvue Corp)|VRNA (Verona Pharma Inc.) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Jyong Biotech Limited MENS|Ligand (LGND) - Kapitalisasi marang bathi|AMRX: Koefisien rega marang bathi|Perrigo - Rasio rega pasar marang bathi resik|ALVO: Pangali P/E|Liquidia Technologies - Nilai perusahaan marang bathi resik|GLPG (Galapagos N.V.) - Pangali P/E|Kapitalisasi marang bathi anipharmaceuticals.com ANIP|Rasio rega marang bathi MannKind (MNKD)|AMPH (Amphastar Pharmaceuticals, Inc.) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Pacira BioSciences, Inc. PCRX|Pangali P/E ARS Corp SPRY|Theravance Biopharma - Pangali P/E|Rasio kapitalisasi marang bathi resik Aquestive Therapeutics, Inc. (AQST)|scPharmaceuticals (SCPH) - Rasio rega marang bathi|Koefisien rega marang bathi Tectonic Therapeutic, Inc.|TNXP (Tonix Pharmaceuticals Holding) - Pangali P/E|Pangali rega marang bathi SXTC (China SXT Pharmaceuticals)|Pangali P/E EPRX|Pangali P/E bioharvest.com (BHST)|Rasio rega marang bathi Invizyne Technologies EXOZ|ORMP: Pangali rega marang bathi|ENTX: Koefisien rega marang bathi|HYFT: Rasio rega marang bathi|ABVC BioPharma Inc. (ABVC) - Rasio rega marang bathi|cumberlandpharma.com (CPIX) - Pangali P/E|QNTM (Quantum BioPharma) - Pangali P/E|FGEN: Nilai perusahaan marang bathi resik|Pangali P/E RANI|SNYR (Synergy CHC) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Rallybio RLYB|Lexaria Bioscience (LEXX) - Kapitalisasi marang bathi|PULM - Rasio rega marang bathi|Periode bali modal bisnis Pheton Holdings PTHL|APM (Aptorum) - Koefisien rega marang bathi|Lyra Therapeutics, Inc. (LYRA) - Pangali P/E|IBO (impactbiomedinc.com) - Pangali P/E|TNFA (TNF Pharmaceuticals) - Rasio rega pasar marang bathi resik|Rasio rega marang bathi cbdmd.com (YCBD)|Periode bali modal bisnis PainReform Ltd|Pangali P/E CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Kapitalisasi marang bathi|OPTN - Rasio rega marang bathi|Pieris Pharmaceuticals - Rasio rega pasar marang bathi resik|PROC (Procaps Group) - Koefisien rega marang bathi|PTPI - Periode bali modal bisnis|Rasio rega marang bathi Qilian International Holding Group Limited|SLRN: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi TFFP (TFF Pharma)